Pharmaceutical Outsourcing

Published on: 09/09/2014

M&A activity in the pharmaceutical outsourcing industry has been strong in 2014, as buyers continue to seek strategic, tuck in acquisitions that can offer any of a number of advantages. These include expanded capabilities that can assist the acquirer in building a full‐service offering, niche research and production technologies and capabilities, expert talent, new geographic markets in this increasingly global market, and access to new blue‐chip customers.

Key Contacts